Search research articles
Contact Us
Filters
Showing results (31-40 of 278) with videos related to
Page
of 28
Sort By:
Antimicrobial Agents and Chemotherapy
|
May 25, 2016
Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates
Mariana Castanheira, Rodrigo E Mendes, Ronald N Jones, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2016
Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014
David J Farrell, Rodrigo E Mendes, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease
|
December 11, 2007
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers
Rodrigo E Mendes, Helio S Sader, Lalitagauri Deshpande, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2019
Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. Hospitals
Mariana Castanheira, Timothy B Doyle, Rodrigo E Mendes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 23, 2022
Antimicrobial activity of high-dose cefepime-tazobactam (WCK 4282) against a large collection of gram-negative organisms collected worldwide in 2018 and 2019
Helio S Sader, Cecilia G Carvalhaes, Rodrigo E Mendes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 20, 2021
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections
Helio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2017
Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae
Mariana Castanheira, Michael D Huband, Rodrigo E Mendes, et al.
BMC Infectious Diseases
|
November 5, 2024
Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales
Helio S Sader, John H Kimbrough, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
October 20, 2010
Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009)
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy
|
February 11, 2016
In vivo emergence of ceftaroline resistance during therapy for MRSA vertebral osteomyelitis
Edgar H Sanchez, Rodrigo E Mendes, Helio S Sader, et al.
Page
of 28
Search research articles
Search
Showing results (31-40 of 278) with videos related to
Sort By:
Page
of 28
Antimicrobial Agents and Chemotherapy
|
May 25, 2016
Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates
Mariana Castanheira, Rodrigo E Mendes, Ronald N Jones, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2016
Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014
David J Farrell, Rodrigo E Mendes, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease
|
December 11, 2007
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers
Rodrigo E Mendes, Helio S Sader, Lalitagauri Deshpande, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2019
Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. Hospitals
Mariana Castanheira, Timothy B Doyle, Rodrigo E Mendes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 23, 2022
Antimicrobial activity of high-dose cefepime-tazobactam (WCK 4282) against a large collection of gram-negative organisms collected worldwide in 2018 and 2019
Helio S Sader, Cecilia G Carvalhaes, Rodrigo E Mendes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 20, 2021
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections
Helio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2017
Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae
Mariana Castanheira, Michael D Huband, Rodrigo E Mendes, et al.
BMC Infectious Diseases
|
November 5, 2024
Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales
Helio S Sader, John H Kimbrough, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
October 20, 2010
Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009)
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy
|
February 11, 2016
In vivo emergence of ceftaroline resistance during therapy for MRSA vertebral osteomyelitis
Edgar H Sanchez, Rodrigo E Mendes, Helio S Sader, et al.
Page
of 28